HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference

TUCSON, Ariz. , Sept. 26, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cantor